Medichecks Inflammation & autoimmunity

Antinuclear Antibodies (ANA) Blood Test

Doctor reviewed

Sample: Blood
Collection: In-store clinic or home nurse visit or venous draw at clinic
Results in: 4 days
Biomarkers: 1
Doctor reviewed: Yes

Tests for

Antinuclear antibodies

Test specifications

Provider: Medichecks
Sample type: blood
Collection method: in-store clinic or home nurse visit or venous draw at clinic
Turnaround time: 4 days
Biomarkers tested: 1
At-home test: No
Doctor reviewed: Yes
Gender focus: Both

What's tested

1 biomarker as listed by Medichecks.

Autoimmunity

Antinuclear antibodies

About this test

Our ANA blood test helps detect antibodies that may indicate autoimmune activity in the body. It's a useful first step in investigating symptoms like fatigue, joint pain, dry eyes, or rashes, guiding further testing if needed. This test doesn't provide a diagnosis but offers valuable insights for understanding potential autoimmune conditions, such as lupus, rheumatoid arthritis, or Sjögren's syndrome.

Description provided by Medichecks.

Our editorial score

Compare Health Test Score

Editorial confidence: 10.0/10

Score breakdown

Clarity and documentation 8.0/10

The listing publishes a short description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
Clinical depth 6.4/10

1 biomarkers, placing it in the 32nd percentile of inflammation tests we track.
Collection convenience 5.0/10

Requires a venous draw at a clinic; a home nurse visit is offered; results within 5 days.
Results and follow-up 7.5/10

Results are reviewed by a doctor.
Trust signals 9.5/10

Trustpilot 4.5 from 2,477 reviews; accredited lab (UKAS ISO 15189 partner labs); doctor review as standard; trading 25+ years.
Value for money 5.9/10

£99.00 against a median of £88.63 for the 26 similarly sized inflammation tests we track (+12%).

Selph

CRP Blood Test for Inflammation

A single high-sensitivity CRP blood test measuring low-grade inflammation, commonly used alongside other risk factors to assess long-term heart disease risk.